Pelago Announces $58 Million Series C Funding to Strengthen Leadership in Substance Use Management
Healthcare IT Today
MAY 2, 2024
Investment Follows Strong Employer and Health Plan Demand as Substance Use Management Moves from Niche Solution to Essential Benefit Resulting in 287% Revenue Growth in 2023 and 100% Client Retention Growth Follows 500% Increase in Substance Use Disorder-Specific RFPs from Employers and Payers in the Past Twelve Months Platform Covers More than 3.4
Let's personalize your content